Literature DB >> 26281030

Impact of novel agents followed by autologous hematopoietic stem cell transplantation for multiple myeloma patients aged 65 years or older: a retrospective single Institutional analysis.

C Minoia1, G Pisapia1, G Palazzo1, C Ingrosso1, M Buonanno1, C Spinosa1, A Prudenzano1, G Pricolo1, P Mazza1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26281030     DOI： 10.1038/bmt.2015.185

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  7 in total

1.  Age and aging in blood disorders: multiple myeloma.

Authors:  Sonja Zweegman; Antonio Palumbo; Sara Bringhen; Pieter Sonneveld
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

2.  Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents.

Authors:  M Merz; K Neben; M S Raab; S Sauer; G Egerer; M Hundemer; D Hose; C Kunz; C Heiß; A D Ho; H Goldschmidt; J Hillengass
Journal:  Ann Oncol       Date:  2014-01       Impact factor: 32.976

3.  Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report.

Authors:  Antonio Palumbo; Sara Bringhen; Maria-Victoria Mateos; Alessandra Larocca; Thierry Facon; Shaji K Kumar; Massimo Offidani; Philip McCarthy; Andrea Evangelista; Sagar Lonial; Sonja Zweegman; Pellegrino Musto; Evangelos Terpos; Andrew Belch; Roman Hajek; Heinz Ludwig; A Keith Stewart; Philippe Moreau; Kenneth Anderson; Hermann Einsele; Brian G M Durie; Meletios A Dimopoulos; Ola Landgren; Jesus F San Miguel; Paul Richardson; Pieter Sonneveld; S Vincent Rajkumar
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

Review 4.  Management of older adults with multiple myeloma.

Authors:  Antonio Palumbo; Roberto Mina
Journal:  Blood Rev       Date:  2013-04-25       Impact factor: 8.250

5.  Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years.

Authors:  H W Auner; R Szydlo; J Hoek; H Goldschmidt; A M Stoppa; G J Morgan; P Moreau; M Attal; G Marit; N Russell; M Brune; G Cook; P Sonneveld; S Schönland; L Garderet; N Kröger
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

6.  European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

Authors:  Monika Engelhardt; Evangelos Terpos; Martina Kleber; Francesca Gay; Ralph Wäsch; Gareth Morgan; Michele Cavo; Niels van de Donk; Andreas Beilhack; Benedetto Bruno; Hans Erik Johnsen; Roman Hajek; Christoph Driessen; Heinz Ludwig; Meral Beksac; Mario Boccadoro; Christian Straka; Sara Brighen; Martin Gramatzki; Alessandra Larocca; Henk Lokhorst; Valeria Magarotto; Fortunato Morabito; Meletios A Dimopoulos; Hermann Einsele; Pieter Sonneveld; Antonio Palumbo
Journal:  Haematologica       Date:  2014-02       Impact factor: 9.941

7.  Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.

Authors:  Shuji Ozaki; Takeshi Harada; Takayuki Saitoh; Chihiro Shimazaki; Mitsuhiro Itagaki; Hideki Asaoku; Yoshiaki Kuroda; Takaaki Chou; Yumiko Yoshiki; Kenshi Suzuki; Hirokazu Murakami; Kunihiko Hayashi; Roberto Mina; Antonio Palumbo; Kazuyuki Shimizu
Journal:  Acta Haematol       Date:  2014       Impact factor: 2.195
  7 in total
  1 in total

1.  Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.

Authors:  Graham H Jackson; Faith E Davies; Charlotte Pawlyn; David A Cairns; Alina Striha; Corinne Collett; Anna Waterhouse; John R Jones; Bhuvan Kishore; Mamta Garg; Cathy D Williams; Kamaraj Karunanithi; Jindriska Lindsay; David Allotey; Salim Shafeek; Matthew W Jenner; Gordon Cook; Nigel H Russell; Martin F Kaiser; Mark T Drayson; Roger G Owen; Walter M Gregory; Gareth J Morgan; Uk Ncri Haematological Oncology Clinical Studies Group
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.